Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Underdose/decent amount of the dose went down the patient's arm; decent amount of the dose went down the patient's arm; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date). On 18-SEP-2025, the patient received the 2nd dose of Shingrix. On 18-SEP-2025, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: Underdose/decent amount of the dose went down the patient's arm) and accidental exposure while administering drug (Verbatim: decent amount of the dose went down the patient's arm). The outcome of the incomplete dose administered and accidental exposure while administering drug were not applicable. Additional Information: GSK Receipt Date: 18-SEP-2025 Reporter reported that the second dose of Shingrix was administered to a patient today and the needle and syringe seem to have not been connected properly and a decent amount of the dose went down the patient's arm. Not sure if any of the dose really made it into patient's arm. So, looking to see if it is appropriate to re-dose or if this would count as a partial dose, not sure how to continue that. The patient was checking with the doctor to see what they would recommend. Reporter looking to see the manufacturer's recommendation of what to do about an improperly administered second Shingrix dose. The batch number was not provided and a request for this information has been made.